Give us your target or disease. We’ll tell you what’s driving it.
No software to learn, no raw data to wrangle. Our scientists trace the signal from altered genes to transcription factors, pathways and master regulators — and hand you a ranked, mechanistic answer.
A low starting fee — the rest only when your targets validate
You bring
Your data and the disease. “We don’t yet know what’s driving it.”
We scope it
One call, then a defined engagement, priced case by case with IP and data terms agreed up front.
You get back
A ranked, mechanistically-justified answer, traceable to the evidence, with optional wet-lab validation.
50+
Funded R&D projects delivered
30+
Disease mechanisms uncovered
3
Drugs repurposed to new indications
1
Novel anti-cancer lead validated
100%
Of results and IP stay with you
Sometimes you don’t want the platform. You want the answer.
We have a result — now what?
A list of differentially expressed genes isn’t a plan. We deliver the mechanism and the next step, not another table.
Too many candidates to rank
We turn a long list into a short, ordered one — built on causal regulatory biology, not statistical association.
Five disconnected tools
Gene to regulation to pathway to disease to target, run as one engagement by the people who built the knowledge.
Every shop runs analyses. Almost none run them on this.
A model can generate a conclusion. It cannot take responsibility for one. A named expert can.
And we put that in writing
Your IP stays yours
Any intellectual property arising from the work belongs to you.
Your data stays protected
Your data is handled under terms agreed before the work begins.
No open questions before we start
Scope, price, IP and data terms are all settled up front.
For teams that want the result — not the tools or the raw data
Pharma & biotech R&D
Narrow an expensive decision — target, indication, combination — before you fund it.
Translational research leads
Turn a promising result into a mechanism and a defensible next experiment.
Teams in regulated pipelines
A traceable, accountable analysis with a named expert behind the conclusion.
Seven service lines, each narrowing an expensive decision
Reconstruction, master-regulator discovery and drug-target priority
Resistance mechanisms and rational combination therapy
Mode of action, toxicity mechanisms and safety-risk intelligence
Synthetic regulatory-element engineering
CRISPR, CAR-T and therapy-design intelligence
Multi-omics panels and companion-diagnostic design
Grounded intelligence for biomedical R&D
Start with strategy. Pay the rest when your targets validate.
Intelligence Package
A scoped analysis that ranks the targets worth pursuing, delivered as a mechanistic report.
Validated targets
The intelligence package plus wet-lab validation of the prioritised targets.
Full translational development
End-to-end development, scoped case by case, from mechanism to a validated lead.
After the work
They didn’t hand us another table — they handed us the mechanism and the next experiment to run.
★★★★★
Head of computational biology
Biotech, Series C
One engagement replaced five disconnected tools, and the answer arrived with the provenance attached.
★★★★★
Director of discovery
Mid-cap pharma
The curation depth is the reason we came. Public sets gave us candidates; this gave us a mechanism we could defend.
★★★★★
Translational research lead
Top-20 pharma
Three ways in, one body of knowledge
Tell us the question. We’ll scope the answer.
One call, then a defined engagement — priced case by case, with a named scientist who stands behind the result.